House
Sign inCreate account
Drug lookup
Drug reference

oxyphedrine

Myocardial metabolism enhancer (claimed) · Antianginal

Myocardial metabolism enhancer (claimed)Antianginal
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated

Mechanism

Claimed to improve myocardial metabolism so that heart can sustain hypoxia better.

Indications

Angina (status not defined)Myocardial infarction (status not defined)

Dosing

Adult
8–24 mg TDS oral, 4–8 mg i.v. OD-BD

Side effects

Common
diminish or alter taste sensation

Related guidelines

ST-elevation myocardial infarction
CSI · Cardiology · 2020
Acute coronary syndrome
CSI · Cardiology · 2022
Status epilepticus
AAN · Neurology · 2020
Primary PCI for acute coronary syndrome
ESC · Cardiology · 2026
Hypertrophic cardiomyopathy
ESC · Cardiology · 2026

Ask House about oxyphedrine

Continue into a citation-backed clinical answer with the drug context already attached.

Open in workspaceAsk House about this drug

Sources: KD Tripathi 7e·Verified: 2026-05-10 · House clinical team